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Abstract
Background: Previous studies showed that C. trachomatis strains found in MSM are different from those in heterosexuals.
This study investigates whether the differences in strain distribution between MSM and heterosexuals are due to tissue
tropism.
Methods: C. trachomatis positive samples were collected from MSM (anorectal) and women (anorectal, cervical, vaginal,
pharyngeal) visiting the STI outpatient clinic of Amsterdam between 2008 and 2013. All samples were typed using
multilocus sequence typing (MLST). Epidemiological data were derived from electronic patient records.
Results: We obtained full MLST data for C. trachomatis from 207 MSM and 185 women, all with anorectal infections.
Six large clusters were identified of which 3 consisted predominantly of samples from women (89%-100%), whereas
the other 3 consisted predominantly of samples from MSM (97%-100%). Furthermore, we obtained full MLST data from
434 samples of 206 women with concurrent infections at multiple anatomical locations. No association was observed
between C. trachomatis cluster and the anatomical location of infection.
Conclusion: We found no indication for tissue tropism in urogenital, pharyngeal and anorectal C. trachomatis infections.
Combined with results from previously conducted studies, we hypothesize that MSM and heterosexuals have different
distributions of C. trachomatis strains due to their separate sexual networks.
Keywords: Chlamydia trachomatis, High-resolution genotyping, Cluster analysis, Men who have sex with men, Sexually
transmitted infections
Background
Chlamydia trachomatis infection is a major public health
problem, as it remains the primary cause of bacterial
sexually transmitted diseases worldwide [1]. C. trachomatis
is capable of infecting various cell types and tissues in the
human body with a considerable number of infections
found in the urogenital tract. Infections also occur in
ocular, anorectal and pharyngeal tissue. Most of these
infections remain asymptomatic. If not properly treated,
these may result in severe complications including
epididymitis and pelvic inflammatory disease, leading
to infertility in women and possibly also in men [2-4].
C. trachomatis is currently divided into 15 main
genovars, according to immunotyping of the major outer
membrane protein (MOMP) or analysis of the coding
ompA gene [5]. These 15 genovars can be grouped into
ocular genovars A to C, anogenital genovars D to K, and
LGV genovars L1 to L3 [6]. Most of the studies using
ompA typing demonstrated that the majority of infec-
tions among heterosexuals involved genovars D, E, and
F, while the majority of infections among MSM involved
genovars D, G, and J [7-11]. In addition, they also dem-
onstrated that genovar prevalence varied by anatomical
site: genovar G is more commonly found in the anorec-
tal tract, whereas other genovars are more common in
the urogenital tract [8,10,12,13].
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We recently reported that genotyping of C. trachomatis
using only one molecular target, the ompA gene, was far
less discriminatory compared to a recently developed
high-resolution multilocus sequence typing (MLST)
system [14]. This high-resolution MLST system has
improved the characterization of strains infecting dif-
ferent populations at risk. Two recent population studies
using this MLST method demonstrated distinct transmis-
sion networks in MSM and heterosexuals [7,15]. C.
trachomatis infections found among heterosexuals
belonged to multiple heterogeneous clusters of various
sizes, whereas the majority of infections found among
MSM belonged to 2 large clusters of strains that circu-
lated exclusively among MSM. One cluster comprised
genovar D samples, and the other genovars G and J.
However, samples from MSM and heterosexuals included
in these population studies were taken from different ana-
tomic sites: samples from MSM were primarily taken from
the anorectal tract, whereas samples from heterosexuals
were taken from the urogenital tract. The occurrence of
these distinct transmission networks between MSM and
heterosexuals might therefore also be explained by tissue
tropism, causing different C. trachomatis sequence types
to be preferentially associated with either the urogenital or
anorectal tract. This may also explain the previously
demonstrated variation in genovar prevalence by anatom-
ical site [8,10,12,13].
Therefore, we investigated whether the differences in
MLST identifiable strain distributions between MSM and
heterosexuals can be explained by tissue tropism. We
assessed: (1) differences in C. trachomatis sequence type
distributions of anorectal infections between MSM and
women, and (2) differences in C. trachomatis sequence
type distributions by anatomical site in women with con-
current infections at multiple anatomic locations.
Methods
Collection of chlamydia-positive samples
For this retrospective analysis we used routinely col-
lected data and samples from women diagnosed with a
C. trachomatis infection from December 2011 until
December 2012 at a visit to the STI outpatient clinic of
the Public Health Service of Amsterdam, the Netherlands.
All women were tested for STI according to standard
procedures, as described previously [7,16]. In brief, swabs
were taken either from the vagina, cervix, urethra, (all
considered urogenital infections), rectum, or pharynx, de-
pending on sexual techniques, risk behaviour, clinical
signs, being notified of an STI, and symptoms associated
with chlamydial infections and other STIs. All collected
swabs were tested for the presence of C. trachomatis RNA
using the Aptima Combo 2 assay (Hologic/Gen-Probe, San
Diego, CA) at the Public Health Laboratory, Amsterdam.
Positive C. trachomatis samples were stored at −20°C. This
analysis was restricted to women who were diagnosed with
either concurrent C. trachomatis infections at multiple
anatomic locations, or with solitary anorectal infections.
Additional demographic and sexual risk behaviour data
were obtained from the electronic patient records from the
STI clinic, which contained data on gender, age, number of
sexual partners in the preceding 6 months, sexual tech-
niques, being notified by a sexual partner, STI related
symptoms, HIV status, and having received money for sex
in the preceding 6 months.
For comparison of anorectal infections among MSM
and women, we selected data from MSM with anorectal
C. trachomatis infections from a previous study [7].
These were MSM visiting the same STI clinic between
July 2008 and August 2009, who reported having had re-
ceptive anal sex with a man in the preceding 6 months.
Full MLST data and additional demographic and sexual
risk behaviour data (from electronic patient records)
were available for all selected MSM [7].
The Medical Ethical Committee of Academic Medical
Center of the University of Amsterdam, The Netherlands
approved this study.
DNA amplification
DNA from all included clinical samples was extracted by
isopropanol precipitation and tested for the presence of
chlamydial DNA using an in-house pmpH LGV qPCR
[11,17]. For isolates that tested negative, DNA was re-
extracted from the original samples and retested. All
samples that repeatedly tested negative were excluded.
For all isolates that tested positive, samples were aggre-
gated in two categories: (1) samples with a cycling
threshold lower than or equal to 35, and (2) isolates
with a cycling threshold higher than 35. The latter
were usually unsuitable for further typing.
Nested PCR and sequencing of MLST regions
DNA isolates were amplified by a nested PCR for the re-
gions ompA, CT046 (hctB), CT058, CT144, CT172, and
CT682 (pbpB) as described previously [7,14]. The inner
PCR for isolates with a qPCR cycling threshold lower
than or equal to 35 were performed with M13-tagged
primers, similar to the standard inner primers. The inner
PCR for isolates with a qPCR cycling threshold higher
than 35 were performed with standard inner primers.
The M13-tagged amplified DNA samples were sent to
the sequence facility of the Academical Medical Center
of Amsterdam for further processing. The non M13-tagged
amplified DNA was processed at the Public Health
Laboratory as described previously [14].
MLST data analysis
The obtained sequences were assembled and trimmed,
using BioNumerics 7 (Applied Maths, Sint-Martens-
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Latem, Belgium). The sequences were checked against the
C. trachomatis MLST database (http://mlstdb.bmc.uu.se).
Only samples in which all six loci were successfully
amplified, sequenced, and identified obtained a full
MLST profile (Sequence type, ST) and were included in
further analysis. Incomplete and low quality samples
were re-amplified and re-sequenced at the Public Health
Laboratory. Minimum spanning trees were generated with
BioNumerics 7 using the MLST profiles. A cluster was
defined as a group of STs differing by not more than
one locus from another ST within that group. Clusters
containing 10 or more samples were defined as large
clusters. To investigate specific characteristics of small
clusters (n < 10) and singletons, we combined these
samples into a residual group.
Statistics
C. trachomatis infections were aggregated into cervical,
urethral, vaginal, anorectal or pharyngeal infections,
based on the anatomical location of sampling. Paired
samples of women with concurrent infections at mul-
tiple anatomic locations were aggregated into concord-
ant or discordant infections based on sequence type
variation between the samples. Paired samples with se-
quence types that belonged to the same cluster were
considered concordant infections, whereas paired sam-
ples with sequence types that belonged to different
clusters were considered discordant infections. All
women were regarded as heterosexuals, as female-to-
female transmission of C. trachomatis is very rare [18].
Differences between groups and clusters were tested
using the Pearson χ2 test for categorical data. Fisher exact
test was used when an expected cell count was <1. For
continuous variables Mann–Whitney U tests and
Kruskall-Wallis tests were used. A P value <0.05 was
considered statistically significant. Generalized estimating
equations (GEE) was used to account for possible correla-
tions among multiple samples of women with discordant
infections. Analyses were performed with SPSS package
version 21.0 (SPSS Inc., Chicago, IL, USA).
Results
Study population and specimens
From December 2011 to December 2012, a total of
17,343 women visited the STI outpatient clinic of the
Public Health Service of Amsterdam, of whom 7,143
were tested for chlamydia on multiple anatomical loca-
tions during the same consultation. Of those, 440 (6.2%)
tested positive for C. trachomatis infections on multiple
anatomic locations, resulting in a total of 926 chlamydia
positive samples (Figure 1). Of these, 856 (92.4%) were
available for typing analysis. In 713 samples (83.3%),
sufficient chlamydial DNA could be demonstrated using
qPCR, and for 585 of these samples (63.1%) derived from
Figure 1 Flowchart indicating the number of samples and individuals included and excluded from the study population. Amsterdam
2008–2012. The MSM samples were previously described [7].
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357 women, full MLST profiles could be obtained. We ex-
cluded 151 women with successfully typed samples from
only one location (Figure 1; group A). The remaining 206
women provided 434 samples comprising 149 (34.3%) cer-
vical samples, 116 (26.7%) urethral samples, 51 (11.8%) va-
ginal samples, 101 (23.3%) anorectal samples, and 17
(3.9%) pharyngeal samples.
During the same period, 98 women were diagnosed with
a solitary anorectal C. trachomatis infection. Of these, 97
(99.0%) samples were available for further testing. In 53 of
these samples (54.1%) sufficient chlamydial DNA could be
demonstrated using qPCR. For 48 of them (90.6%), full
MLST profiles could be obtained. In addition to these 48
samples, we had 137 anorectal samples with full MLST
profiles derived from group A (Figure 1). Together these
185 anorectal samples constituted group B (Figure 1).
Overall, no significant differences were observed between
women included and excluded from the study for age,
Table 1 Demographic and sexual risk behavior characteristics of women and men who have sex with men (MSM) with
anorectal Chlamydia trachomatis infections
Variable Total (N = 392) Women (N = 185) MSM (N = 207)
* n (%) * n (%) * n (%) P
Demographics
Age in years (continuous) 383 185 198 <0.001
Median (IQR) 28 (22–39) 23 (20–26) 38 (31–45)
Age in years (categorical) 383 185 198 <0.001
≤15 1 (0.3%) 1 (0.5%) 0 (0.0%)
15-19 25 (6.5%) 25 (13.5%) 0 (0.0%)
20-24 107 (27.9%) 95 (51.4%) 12 (6.1%)
25-29 72 (18.8%) 41 (22.2%) 31 (15.7%)
30-39 84 (21.9%) 15 (8.1%) 69 (34.8%)
≥40 94 (24.5%) 8 (4.3%) 86 (43.4%)
Sexual behavior
Number of partners in preceding 6 months (continuous) 286 185 188 <0.001
Median (IQR) 4 (2–10) 3 (1–5) 10 (4–20)
Receptive anal intercourse 381 183 198 <0.001
Nonea 31 (8.1%) 22 (12.0%) 1 (0.5%)
Safe 70 (18.4%) 16 (8.7%) 54 (27.3%)
Unsafeb 280 (73.5%) 145 (79.2%) 143 (72.2%)
Notified of STI by a sexual partner 383 185 198 0.961
No 306 (79.9%) 148 (80.0%) 158 (79.8%)
Yes 77 (20.1%) 37 (20.0%) 40 (20.2%)
STI related symptoms 383 185 198 <0.001
No 233 (60.8%) 132 (71.4%) 101 (51.0%)
Yes 150 (39.2%) 53 (28.6%) 97 (49.0%)
HIV status 392 185 207 <0.001
Unknown 19 (4.8%) 3 (1.6%) 16 (7.7%)
Negative 278 (70.9%) 182 (98.4%) 96 (46.4%)
Positive 95 (24.2%) 0 (0.0%) 95 (45.9%)
Received money for sex in preceding 6 months 383 185 198 <0.001
No 354 (92.4%) 158 (85.4%) 196 (99.0%)
Yes 29 (7.6%) 27 (14.6%) 2 (1.0%)
Abbreviations: MSM men who have sex with men, STI sexual transmitted infection, HIV human immunodeficiency virus, IQR interquartile range, P P-value.
Significant P-values in bold.
*Number of individuals with available data.
aOf all women reporting no receptive anal intercourse, 14 were prostitutes and were also tested for rectal C. trachomatis infections following routine guidelines, 5
women were accidently tested, 3 women were tested for reporting anal discharge, and 1 women was tested due to notification by a sexual partner.
bEight women reported receptive anal intercourse but condom use was unknown. These were all included as having unsafe receptive anal intercourse, as this
would be the most likely explanation for infection.
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ethnicity, number of sexual partners in the previous
6 months, vaginal intercourse, receptive anal intercourse,
active oral intercourse, being notified of an STI by a sexual
partner, STI related complaints, HIV status and having
received money for sex in the previous 6 months. For
comparison, 207 anorectal samples from MSM with a full
MLST profile were included from a previous study [7]
(Figure 1; group C).
Comparison of MSM and women with anorectal infections
Data of 185 anorectal samples from women (group B;
Figure 1) and 207 anorectal samples from MSM (group
C, Figure 1) were available for analysis. Almost all demo-
graphic and sexual risk behaviour characteristics differed
significantly between MSM and women (Table 1). The
median age of all women with a fully typed anorectal
sample was 23 years (IQR 20–26 years) and their median
number of partners during the last 6 months was 3
(IQR 1–5). In comparison, MSM were significantly
older (P <0.001) with a median age of 38 years (IQR
31–45 years) and reported more sexual partners during
the last 6 months, with a median of 10 partners (IQR
4–20; P < 0.001). In addition, MSM were more frequently
HIV positive (P < 0.001), but fewer MSM reported hav-
ing received money for sex in the previous 6 months
(P < 0.001; Table 1).
Using the complete MLST profiles of all 392 anorectal
samples of MSM and women, 119 STs could be identi-
fied. Of these STs 38 had multiple representatives (2 to
47 isolates) while 81 were found in only a single isolate
(singletons). Using these STs, a minimum spanning tree
was generated, in which 6 large clusters could be identi-
fied (Figure 2). These clusters ranged from 19 to 93
samples comprising 87.5% of all samples. The remaining
49 samples from MSM and women had more than one
locus difference compared to other samples that were in-
cluded in the large clusters, and therefore constituted the
residual group. These remaining samples were distributed
over 23 singletons and 6 small clusters, ranging from 2 to
7 samples. The minimum spanning tree shows a clear dis-
tinction between samples from MSM and women. Of the
6 large clusters, 3 consisted predominantly of samples
from women (83.9% to 100%) whereas the other 3 large
clusters consisted predominantly of samples from MSM
(96.8% to 100%). Outside the identified large clusters, 7
samples were from MSM and 42 samples were from
women. Overall, the samples from women showed more
genetic diversity than those from MSM.
The clusters dominated by women consisted of
genovars D, E, F, I, and J, with genovars D, E, and F
being most prominent. In comparison, the clusters
dominated by MSM consisted of genovars D, G, J, L2,
and L2b, with genovars D, G, J, and L2b being most
prominent. The residual group, consisting of the
remaining small clusters and singletons, included a wide
variety of genovars, but genovars D and G were most
common (Table 2).
Cluster analysis of MSM and women with anorectal
infections
We observed significant differences for gender, age, num-
ber of partners in the preceding 6 months, receptive anal
intercourse, STI related symptoms, HIV status and having
received money for sex in the preceding 6 months between
all clusters. However, no significant differences could be
observed when comparing only the residual group and the
clusters dominated by women (cluster I-III; PI-III+R,
Table 2). These findings are fully in line with previous
findings by our group in which distinct circulating C.
trachomatis strains were found among MSM and hetero-
sexuals, as was discussed elsewhere [7].
Comparing the MSM dominated clusters (cluster IV-
VI, Table 2), significant differences were observed in the
number of sexual partners in the preceding 6 months
(P = 0.014; PIV-VI Table 2). MSM in the LGV cluster re-
ported more sexual partners (median of 10 (IQR, 10–20))
compared to MSM in the other MSM dominated clusters
(median of 5 (IQR, 3–20)). Significant differences were
also observed for STI related complaints (P = 0.007; PIV-VI
Table 2). A larger proportion of MSM in the LGV cluster
reported STI related complaints (66.7%) compared to MSM
in the other MSM dominated clusters (36.8 to 41.8%).
Figure 2 Minimum spanning tree showing the MLST pattern of
392 Chlamydia trachomatis positive anorectal samples from
MSM and women. Each circle represents one ST. Size of the circles
is proportional to the number of identical ST profiles. Bold lines
connect types that differ for one single locus. Halos indicate the
distinct clusters. The color coding is: green, men who have sex with
men (n = 207); red, heterosexual women (n = 185).
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Table 2 Demographic and sexual risk behavior characteristics of women and MSM with anorectal infections by
Chlamydia trachomatis MLST cluster
Variable Cluster I Cluster II Cluster III Cluster IV Cluster V Cluster VI Residual
PI-III+R P IV-VI P IV+V P total
n = 79 n = 56 n = 19 n = 93 n = 56 n = 40 n = 49
ompA Genovar - - - -
B 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (2.0%)
D 0 (0.0%) 9 (16.1%) 1 (5.3%) 0 (0.0%) 56 (100.0%) 0 (0.0%) 12 (24.5%)
E 79 (100.0%) 4 (7.1%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 8 (16.3%)
F 0 (0.0%) 43 (76.8%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 2 (4.1%)
G 0 (0.0%) 0 (0.0%) 0 (0.0%) 64 (68.8%) 0 (0.0%) 0 (0.0%) 10 (20.4%)
H 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 4 (8.2%)
I 0 (0.0%) 0 (0.0%) 15 (78.9%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 3 (6.1%)
J 0 (0.0%) 0 (0.0%) 3 (15.8%) 29 (31.2%) 0 (0.0%) 0 (0.0%) 6 (12.2%)
K 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 3 (6.1%)
L2 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 3 (7.5%) 0 (0.0%)
L2b 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 37 (92.5%) 0 (0.0%)
Demographics
Gender 0.095 0.207 0.175 <0.001
Male 5 (6.3%) 9 (16.1%) 0 (0.0%) 90 (96.8%) 56 (100.0%) 40 (100.0%) 7 (14.3%)
Female 74 (93.7%) 47 (83.9%) 19 (100.0%) 3 (3.2%) 0 (0.0%) 0 (0.0%) 42 (85.7%)
Age in years
(continuous)a
0.438 0.112 0.089 <0.001
Median (IQR) 23 (21–27) 23 (20–
28)
22 (21–24) 37 (29–
45)
38 (29–45) 43 (35–46) 25 (20–29)
Age in years
(categorical)a
0.656 0.359 0.951 <0.001
<15 0 (0.0%) 1 (1.8%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
15-19 10 (12.7%) 7 (12.7%) 3 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 5 (10.2%)
20-24 40 (50.6%) 25 (45.5%) 12 (0.0%) 6 (6.9%) 5 (9.1%) 0 (0.0%) 19 (38.8%)
25-29 14 (17.7%) 13 (23.6%) 2 (0.0%) 16 (18.4%) 9 (16.4%) 3 (7.7%) 15 (30.6%)
30-39 12 (15.2%) 6 (10.9%) 1 (0.0%) 27 (31.0%) 18 (32.7%) 15 (38.5%) 5 (10.2%)






0.396 0.014 0.463 <0.001
Median (IQR) 3 (2–6) 3 (2–6) 2 (1–3) 5 (3–20) 5 (3–10) 10 (10–20) 3 (1–6)
Receptive anal
intercoursec
0.863 0.056 0.524 <0.001
None 9 (16.7%) 4 (13.0%) 1 (10.5%) 2 (2.3%) 0 (0.0%) 0 (0.0%) 7 (14.3%)
Safe 7 (9.0%) 7 (13.0%) 2 (10.5%) 27 (31.0%) 17 (30.9%) 4 (10.3%) 6 (12.2%)
Unsafed 62 (74.4%) 43 (74.1%) 16 (78.9%) 58 (66.7%) 38 (69.1%) 35 (89.7%) 36 (73.5%)
Notified of STI by
a sexual partnera
0.301 0.740 0.750 0.556
No 69 (87.3%) 41 (74.5%) 15 (78.9%) 66 (75.9%) 43 (78.2%) 32 (82.1%) 40 (81.6%)
Yes 10 (12.7%) 14 (25.5%) 4 (21.1%) 21 (24.1%) 12 (21.8%) 7 (17.9%) 9 (18.4%)
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Finally, significant differences were observed for HIV
status (P < 0.001; PIV-VI Table 2) A larger proportion of
MSM in the LGV cluster were HIV positive (85.0%)
compared to MSM in the other MSM dominated clus-
ters (33.3 to 39.3%). These differences were therefore
mainly due to the LGV cluster that is known to prevail
among a core group of high risk MSM [7,19,20]. When
we excluded the LGV cluster (cluster VI) from the ana-
lysis, no significant differences were observed between
the remaining two MSM clusters, as was shown previ-
ously by our group [7].
Comparison of women with concurrent infections at
multiple anatomic locations
The median age of the 206 women with concurrent infec-
tions at multiple anatomic locations (group A, Figure 1)
was 22 years (IQR 16–28 years) and their median number
of partners during the last 6 months was 3 (IQR 1–6)
(Table 3). Using the complete MLST profile of all 434
samples of these 206 women, 126 unique STs could be
identified of which 51 were novel to the C. trachomatis
MLST database (http://mlstdb.bmc.uu.se). Novel STs were
numbered in order of identification and were found in 88
(20.1%) of 434 samples. Of all identified STs 79 had mul-
tiple representatives (2 to 50 isolates) while 47 were found
in only a single isolate (singletons). Using the STs of all of
these samples, a minimum spanning tree was generated,
in which 4 large clusters could be identified (Figure 3).
These clusters ranged from 46 to 123 samples comprising
75.3% of all samples. The remaining 108 samples were dis-
tributed over 47 singletons and 10 small clusters, ranging
from 2 to 9 samples.
The minimum spanning tree shows a heterogeneous
distribution of STs found per anatomic location (Figure 3).
The 4 large clusters contained genovars D, E, F, I, and J,
with genovars D, E, and F being most prominent. The re-
sidual group containing the remaining small clusters and
singletons included all genovars with a majority of
genovars D, E, and G. Overall, no significant differ-
ences could be observed when comparing the proportions
of cervical, urethral, vaginal, anorectal or pharyngeal infec-
tions between all clusters and the residual group (Table 4).
Discordant infections among women with concurrent
infections at multiple anatomic locations
Analysis of STs found among all samples from 206
women with concurrent infections at multiple anatomic
locations identified 376 samples from 179 women
(86.9%; 95% CI [81.8-91.0%]), in whom all concurrent
infections were caused by the same (concordant) chlamydia
strains belonging to the same clusters. For 264 samples
from 153 (74.3%; 95% CI [68.0-79.9%]) of these women,
concordant strains had an identical ST, and for 54 samples
from 26 (12.6%; 95% CI [8.6-17.6%]) women the ST differed
at 1 locus between concurrent samples. The remaining
58 samples belonged to 27 women (13.1%; 95% CI [9.0-
18.2%]) who had concurrent infections caused by dis-
cordant C. trachomatis strains, belonging to different
Table 2 Demographic and sexual risk behavior characteristics of women and MSM with anorectal infections by
Chlamydia trachomatis MLST cluster (Continued)
STI related
symptomsa
0.778 0.007 0.548 0.014
No 55 (69.6%) 34 (61.8%) 13 (68.4%) 55 (63.2%) 32 (58.2%) 13 (33.3%) 31 (63.3%)
Yes 24 (30.4%) 21 (38.2%) 6 (31.6%) 32 (36.8%) 23 (41.8%) 26 (66.7%) 18 (36.7%)
HIV status 0.627 <0.001 0.556 <0.001
Unknown 0 (0.0%) 2 (3.6%) 1 (5.3%) 9 (9.7%) 3 (5.4%) 3 (7.5%) 1 (2.0%)
Negative 75 (94.9%) 52 (92.9%) 18 (94.7%) 53 (57.0%) 31 (55.4%) 3 (7.5%) 46 (93.9%)
Positive 4 (5.1%) 2 (3.6%) 0 (0.0%) 31 (33.3%) 22 (39.3%) 34 (85.0%) 2 (4.1%)
Received money
for sex in preceding
6 monthsa
0.822 0.581 0.425 <0.001
No 65 (82.3%) 50 (90.9%) 17 (89.5%) 86 (98.9%) 55 (100.0%) 39 (100.0%) 42 (85.7%)
Yes 5 (6.3%) 5 (9.1%) 2 (10.5%) 1 (1.1%) 0 (0.0%) 0 (0.0%) 7 (14.3%)
Abbreviations: MSM men who have sex with men, STI sexual transmitted infection, HIV human immunodeficiency virus, IQR interquartile range, P P-value.
Ptotal represents the p-value for the analysis over all clusters and the residual group; PI-III+R over clusters I to III and the residual group consisting predominantly of
women; PIV-VI over clusters VI tot VI consisting predominantly of MSM including the LGV cluster. PIV-V over clusters IV and V consisting predominantly of MSM
excluding the LGV cluster.
Significant P-values in bold.
aData is missing for 1 cluster II infection, 6 cluster IV infections, 1 cluster V infection, and 1 cluster VI infection.
bData is missing for 3 cluster I infections, 4 cluster II infections, 45 cluster IV infections, 16 cluster VI infections, and 4 residual infections.
cData is missing for 1 cluster I infection, 2 cluster II infections, 6 cluster IV infections 1 cluster V infection, and 1 cluster VI infection.
dEight women reported receptive anal intercourse but condom use was unknown. These were all included as having unsafe receptive anal intercourse, as this
would be the most likely explanation for infection.
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Table 3 Demographic and sexual risk behavior characteristics of women with concurrent concordant- and discordant
multiple Chlamydia trachomatis infections
Variable Total (N = 206) Concordant (N = 179) Discordant (N = 27)
* n (%) * n (%) * n (%) P
Demographics
Age in years (continuous) 206 179 27 0.321
Median (IQR) 22 (20–26) 22 (20–26) 21 (19–26)
Age in years (categorical) 206 179 27 0.213
<15 0 (0.0%) 0 (0.0%) 0 (0.0%)
15-19 38 (18.4%) 30 (16.8%) 8 (29.6%)
20-24 105 (51.0%) 95 (53.1%) 10 (37.0%)
25-29 43 (20.9%) 35 (19.6%) 8 (29.6%)
30-39 13 (6.3%) 12 (6.7%) 1 (3.7%)
≥40 7 (3.4%) 7 (3.9%) 0 (0.0%)
Ethnicity 206 179 27 0.327
Dutch 97 (47.1%) 84 (46.9%) 13 (48.1%)
Surinamese 38 (18.4%) 30 (16.8%) 8 (29.6%)
Eastern European 22 (10.7%) 20 (11.2%) 2 (7.4%)
Other 49 (23.8%) 45 (25.1%) 4 (14.8%)
Sexual behavior
Number of partners in
preceding 6 months (continuous)
206 179 27 0.545
Median (IQR) 3 (2–5) 3 (2–5) 3 (1–6)
Vaginal intercourse 203 177 26 0.831
Safe 21 (10.3%) 18 (10.2%) 3 (11.5%)
Unsafe 182 (89.7%) 159 (89.8%) 23 (88.5%)
Receptive anal intercourse 205 179 26 0.797
None 110 (53.7%) 97 (54.2%) 13 (50.0%)
Safe 17 (8.3%) 14 (7.8%) 3 (11.5%)
Unsafe 78 (38.0%) 68 (38.0%) 10 (38.5%)
Active oral intercourse 203 177 26 0.969
None 28 (13.8%) 24 (13.6%) 4 (15.4%)
Safe 8 (3.9%) 7 (4.0%) 1 (3.8%)
Unsafe 167 (82.3%) 146 (82.5%) 21 (80.8%)
Notified of STI by a
sexual partner
206 179 27 0.435
No 143 (69.4%) 126 (70.4%) 17 (63.0%)
Yes 63 (30.6%) 53 (29.6%) 10 (37.0%)
STI related symptoms 206 179 27 0.209
No 87 (42.2%) 70 (39.1%) 17 (63.0%)
Yes 122 (59.2%) 109 (60.9%) 13 (48.1%)
HIV status 206 179 27 0.679
Unknown 4 (1.9%) 4 (2.2%) 0 (0.0%)
Negative 201 (97.6%) 174 (97.2%) 27 (100.0%)
Positive 1 (0.5%) 1 (0.6%) 0 (0.0%)
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clusters. Of those, 6 women had concurrent samples
that differed at 2 loci and 21women had concurrent
samples that differed at 3 or more loci. Statistical ana-
lysis of demographic and sexual risk behaviour charac-
teristics revealed no significant differences between women
with concordant and discordant infections (Table 3). In
addition, no significant differences could be observed when
comparing the proportion of concordant and discordant
infections between all clusters and the residual group
(Figure 4; Table 4).
Discussion
In this study, we observed that anorectal C. trachomatis
infections in women were caused by different strains
than anorectal C. trachomatis infections in MSM. We
eliminated the discrepancy in anatomical sample site
and still observed largely distinct C. trachomatis strains
infecting MSM and women. We found that C. trachomatis
infections circulating among women belonged to 3
heterogeneous clusters of various sizes, whereas the
majority of infections found among MSM belonged to
3 homogeneous clusters.
We did not include C. trachomatis strains from male
urethra since this is a common factor in the transmission
among both MSM and heterosexual women. As a result
this would not add discriminative data to a possible tissue
related role in the distribution of strains between the 2
populations. Previous studies hypothesized that pathogen-
related factors such as tissue tropism could explain the
distinct distribution of C. trachomatis strains circulating
among MSM and heterosexual populations, but lacked
data to test this hypothesis [7,15]. We now tested this
hypothesis and compared identical anatomical sites be-
tween MSM and women, but observed hardly any overlap
of strains circulating among MSM and women suggesting
that these distinct distributions of C. trachomatis strains is
not caused by tissue tropism. Therefore, we hypothesize
that the distinct distributions of C. trachomatis strains
among MSM and women is caused by network factors,
and that limited transmission of C. trachomatis strains oc-
curs between MSM and heterosexual networks. Moreover,
sexual behaviour may also influence the distinct distribu-
tions of C. trachomatis strains among MSM and women
as we observed differences in demographic and sexual risk
behaviour characteristics between MSM and women:
MSM were significantly older and had had more sexual
partners in the previous 6 months. We observed no differ-
ences in demographic, or sexual behaviour characteristics
between clusters consisting of samples derived from
women.
We focused on tissue tropism in cervical, urethral,
vaginal, anorectal and pharyngeal infections that are
primarily caused by the anogenital genovars D to K, and
the LGV genovars L1 to L3. Recent studies reported on
several pathogen and host genes related to disease severity
and tissue tropism [5,21-24], but these studies focused
primarily on the molecular basis underlying the disparities
between ocular, genital, and LGV associated genovars.
Although we did not find any indication for tissue tropism
within the urogenital strains, the possible role of tissue
tropism on the prevalence of anorectal LGV infections
could not be determined, as our study did not include
urogenital samples from MSM. However, recent studies
and case reports have described urethral and pharyngeal
Table 3 Demographic and sexual risk behavior characteristics of women with concurrent concordant- and discordant
multiple Chlamydia trachomatis infections (Continued)
Received money for sex in
preceding 6 months
206 179 27 0.263
Yes 175 (85.0%) 154 (86.0%) 21 (77.8%)
No 31 (15.0%) 25 (14.0%) 6 (22.2%)
Abbreviations: STI sexual transmitted infection, HIV human immunodeficiency virus, IQR interquartile range, P P-value.
Significant P-values in bold.
*Number of individuals with available data.
Figure 3 Minimum spanning tree showing the MLST pattern of
434 Chlamydia trachomatis positive samples from 206 women
with concurrent infections at multiple anatomic locations. Each
circle represents one MLST type. Size of the circles is proportional to
the number of identical STs. Bold lines connect types that differ for
one single locus. Halos indicate the distinct clusters. Colors indicate
the anatomic location of sampling; pink: cervical samples (n = 149),
cyan: urethral samples (n = 116), orange: vaginal samples (n = 51),
blue: anorectal samples (n = 101), and yellow: pharyngeal samples (n = 17).
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LGV infections in MSM, and urogenital and cervical in-
fections among women [20,25-27], suggesting at least no
specific preference of LGV-inducing strains to solely infect
anorectal tissue. Since anorectal LGV infections primarily
occur in a subpopulation of HIV infected MSM with high
risk sexual behaviour and high numbers of sexual part-
ners, it is possible that this is also due to differences in
host immunity, sexual behaviour and network associated
factors. The lack of knowledge on the pathogenicity and
transmission of LGV-inducing strains indicates the need
for further research to clarify the predominant occurrence
of anorectal LGV infections in comparison to urogenital
and pharyngeal LGV infections.
To further investigate the possible role of tissue
tropism in the distribution of C. trachomatis strains,
we compared concurrent C. trachomatis strains detected
in women at multiple anatomic locations. We did not ob-
serve any significant differences in the proportion of
urogenital, anorectal or pharyngeal infections between
clusters suggesting that C. trachomatis strains do not pref-
erentially infect urogenital, anorectal, or pharyngeal tissue.
Thus, these findings contradict previous studies reporting
that the prevalence of C. trachomatis genovars varies by
anatomical site and that genovar G is more commonly
Figure 4 Minimum spanning tree showing the MLST pattern of
434 Chlamydia trachomatis positive samples from 206 women
with concurrent infections at multiple anatomic locations. Each
circle represents one MLST type. Size of the circles is proportional to
the number of identical STs. Bold lines connect types that differ for
one single locus. Halos indicate the distinct clusters. White indicates
concordant samples (maximum 1 locus difference in MLST profile
between infections) within one woman. Colors indicate discordant
samples, with a unique color for each of the 27 women. Discordant
is more than 1 locus difference in MLST profile between infections.
Table 4 Characteristics of Chlamydia trachomatis infections among women with concurrent infections at multiple
anatomic locations, by Chlamydia trachomatis MLST cluster
Variable Cluster I Cluster II Cluster III Cluster IV Residual P
n = 121 n = 60 n = 99 n = 46 n = 108
ompA genovar -
B 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 4 (3.7%)
D 0 (0.0%) 0 (0.0%) 19 (19.2%) 2 (4.3%) 18 (16.7%)
E 121 (100.0%) 60 (100.0%) 0 (0.0%) 1 (2.2%) 21 (19.4%)
F 0 (0.0%) 0 (0.0%) 74 (74.7%) 0 (0.0%) 10 (9.3%)
G 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 24 (22.2%)
H 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 9 (8.3%)
I 0 (0.0%) 0 (0.0%) 0 (0.0%) 34 (73.9%) 3 (2.8%)
J 0 (0.0%) 0 (0.0%) 6 (6.1%) 9 (19.6%) 12 (11.1%)
K 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 7 (6.5%)
Anatomic location of infection 0.968
Cervical 40 (33.1%) 21 (35.0%) 37 (37.4%) 13 (28.3%) 38 (35.2%)
Urethral 33 (27.3%) 17 (28.3%) 25 (25.3%) 13 (28.3%) 28 (25.9%)
Vaginal 13 (10.7%) 8 (13.3%) 9 (9.1%) 8 (17.4%) 13 (12.0%)
Anorectal 28 (23.1%) 13 (21.7%) 24 (24.2%) 12 (26.1%) 24 (22.2%)
Pharyngeal 7 (5.8%) 1 (1.7%) 4 (4.0%) 0 (0.0%) 5 (4.6%)
Discordant multiple infectionsa 0.330*
No 110 (90.9%) 51 (85.0%) 87 (87.9%) 40 (87.0%) 88 (81.5%)
Yes 11 (9.1%) 9 (15.0%) 12 (12.1%) 6 (13.0%) 20 (18.5%)
Abbreviation: P P-value.
*GEE is used.
aDiscordant multiple infections defined as: having ≥ 2 paired samples with sequence types that belonged to different clusters.
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found in the anorectal tract [8,10,12,13]. Our findings
suggest that there is no strain that can be specifically
associated with anorectal infections, as the anorectal C.
trachomatis infecting strain is generally identical to
strains causing a concurrent pharyngeal or urogenital
C. trachomatis infection. We did identify some discord-
ant infections among women with concurrent infections
at multiple anatomic locations. Although these discordant
infections may best be explained by sexual risk behaviour,
causing women to concurrently get infected with multiple
different C. trachomatis strains, we could not identify any
significant difference in sexual risk behaviour characteris-
tics compared to those with concordant infections. The
most likely reason for discordant infection remains separ-
ate infections due to different sexual partners, as all women
were STI clinic visitors who are known to be engaged in
more risky sexual behaviour.
Some potential limitations of this study should be
noted. We excluded a large number of samples as these
were no longer available at the public health laboratory,
had insufficient chlamydial DNA for typing, or could
not be fully typed. Exclusion of these samples resulted in
the inclusion of only a limited number of pharyngeal
samples with the potential of a biased population. An-
other limitation is the difference in sample collection
between high-risk and low-risk visitors of the STI out-
patient clinic. Visitors were allocated to a standard or
limited screening protocol depending on reported sex-
ual behaviour. Criteria for a standard approach were:
having STI related physical complaints; being notified
of STI exposure by a sexual partner; having been paid
for sexual contact in the past 6 months and for males,
having had sex with men in the past 6 months [7,16].
In the standard protocol, samples were taken by a
trained nurse, and in the limited protocol these were
self-swabs. Although women were carefully instructed
on how to collect self-swabs, careless self-taken anorec-
tal swabs by low-risk women might have been contami-
nated by a urogenital C. trachomatis infection due to
the short anogenital distance.
Conclusions
Using high-resolution multilocus sequence typing we found
no indication for tissue tropism in urogenital C. trachomatis
strains. Combined with results from previously conducted
studies, we hypothesize that MSM and heterosexuals have
different distributions of C. trachomatis strains due to their
separate sexual networks.
Further research needs to provide more insight in the
predominant occurrence of anorectal LGV infections in
comparison to urogenital or pharyngeal LGV infections
and whether or not this can be explained by tissue
tropism.
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